From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

The Food and Drug Administration in the US has just approved Cobenfy, which one researcher referred to as a "game changer" ...

Bristol Myers Squibb (BMS) acquired Karuna Therapeutics, the developer of KarXT, in a deal worth US $14.0 billion in equity ...

Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating on September 26. David Risinger ...

Warren Buffett is famous for being a value investor while Peter Lynch tended to be growth-oriented. Some investors are ...

Dividend investing has become increasingly popular over time, as generating regular income remains a key focus for investors.

Depending on how long it lasts, the dockworkers strike that hit all 14 ports on the U.S. East Coast and along the Gulf Oct. 1 could literally unload a world of hurt to patients and the ...

In a report released on September 27, Faisal Khurshid from Leerink Partners reiterated a Buy rating on PureTech Health (PRTC – Research ...

Kent Imaging Inc. is looking to raise $25 million in a series B financing round to expand the use of its imaging device for measuring wound and tissue oxygenation, and to support the launch of a new ...

Speaker Mike Johnson is blasting Democrats for being “hypocritical” when it comes to standing with Israel after Iran’s ballistic missile attacks on Tuesday. The GOP leader kicked off a ...

Legislators in Kenya have started the process of removing the country's deputy president from office. Africans studying in Beirut are having to weigh up whether or not they should leave the ...

The attack, which ended shortly after it began, capped a chaotic 24-hour period that began with Israel’s invading of Lebanon in pursuit of Hezbollah. Iran fired a barrage of ballistic missiles ...